ARCHIVES

House Committee Asks Varmus About Impact of Clinical Center construction On NIH Programs

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Senate Commitee Approves $1.058 Trillion To Reverse Sequestration Cuts

June 21, 2013

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

NCI Advisors Approve $20.5M Program Of Grants, Contracts For Biospecimen Research.

July 6, 2007

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009